AR-positive inclusion bodies were detected in MNs in SBMA patients [13,14], as well as in pheochromocytoma (PC12) cells expressing an AR with 112 glutamine residues in response to androgen treatment [15] and agents capable of promoting inclusion body formation showed protective effects in cell and fly models of SBMA [16]. The gene discussed is AR; the disease is Kennedy disease.